Lipoxin A4 reduces inflammation through formyl peptide receptor 2/p38 MAPK signaling pathway in subarachnoid hemorrhage rats
Z Guo, Q Hu, L Xu, ZN Guo, Y Ou, Y He, C Yin, X Sun… - Stroke, 2016 - Am Heart Assoc
Background and Purpose—Lipoxin A4 (LXA4) has been reported to reduce inflammation in
several neurological injury models. We studied the effects of LXA4 on neuroinflammation
after subarachnoid hemorrhage (SAH) in a rat model. Methods—Two hundred and thirty …
several neurological injury models. We studied the effects of LXA4 on neuroinflammation
after subarachnoid hemorrhage (SAH) in a rat model. Methods—Two hundred and thirty …
For custom peptides, please visit www.pepmic.com. Our peptide services including but not limited to:
*Peptide Synthesis: From short peptides to long peptides, linear peptides to cyclic peptides.
*Peptide Modifications: Peptide-protein conjugation, D-amino acid peptides, isotope peptides, fluorescent peptides, multiple antigen peptides, multiple disulfide bridge peptides, phosphopeptides etc.
*Catalog Peptides: ACE Inhibitors, Amyloids & Related Peptides, Antimicrobial Peptides, Apelin Peptides, Myelin Oligodendrocyte Glycoprotein (MOG) Peptides, TAT Proteins etc.
*Peptide Salt: TFA, Desalt, Acetate, HCl.
*Peptide Purity: From crude to ＞99.5%.
*Production Capacity: From mg to kg, with a capacity of synthesizing 15,000 peptides/month.
*Peptide Library Synthesis: Alanine Scan, Overlapping, Positional Scan, T-cell Truncated, Scrambled ect.
Quick Links:
Contact Information:
Eva He
eva@pepmic.com
Pepmic Co., Ltdeva@pepmic.com
www.pepmic.com
没有评论:
发表评论